Caspase & Granzyme B Inhibitors

Our Caspase & Granzyme B Inhibitors are innovative compounds that hold tremendous potential in the field of immunology and cancer research Caspases and granzyme B are enzymes involved in apoptosis programmed cell death and their dysregulation can have profound implications for various diseases including cancer By specifically targeting and inhibiting these enzymes our inhibitors offer a unique approach to modulating cell death pathways and potentially finding new therapeutic strategies With their high potency and selectivity our Caspase & Granzyme B Inhibitors are valuable tools for researchers aiming to unravel the complexities of cell death mechanisms and develop novel treatments for a range of diseases

Catalog Number	Chemical Name	CAS #	Price
BC-0867	Caspase-Family Inhibitor Z-VAD-FMK	187389-52-2	Online Inquiry
BC-0869	FMK Negative Control	197855-65-5	Online Inquiry
EI-0207	Apoptosis inhibitor	54135-60-3	Online Inquiry
EI-0278	AZ10417808	331645-84-2	Online Inquiry
EI-0515	Caspase-3 Inhibitor, Ac-DMQD-CHO	259199-63-8	Online Inquiry
EI-0516	Caspase-3/7 Inhibitor	220509-74-0	Online Inquiry
EI-0807	Emricasan	254750-02-2	Online Inquiry
EI-1241	Ivachtin	745046-84-8	Online Inquiry
EI-1537	MX1013	582316-00-5	Online Inquiry
EI-2295	VX-765	273404-37-8	Online Inquiry
EI-2340	Z-AEVD-FMK	1135688-47-9	Online Inquiry
EI-2341	Z-FA-FMK	105637-38-5	Online Inquiry
EI-2520	Ac-DEVD-CHO	169332-60-9	Online Inquiry

Application

The Caspase & Granzyme B inhibitors are valuable tools in both research and medicine In the field of research these inhibitors are commonly used to study the role of caspases and granzyme B in different biological processes By selectively blocking the activities of these enzymes scientists can gain insights into their functions and their involvement in diseases such as cancer and neurodegenerative disorders

In medicine Caspase & Granzyme B inhibitors have potential therapeutic applications Caspases are key players in apoptosis or programmed cell death which is a crucial process in maintaining tissue homeostasis By inhibiting caspase activity these inhibitors can potentially be used to modulate cell death and prevent excessive tissue damage in various disease conditions

Similarly Granzyme B is an enzyme released by cytotoxic T cells and natural killer cells to induce apoptosis in target cells By inhibiting Granzyme B it may be possible to regulate immune responses and reduce cell death in autoimmune diseases or tissue damage caused by excessive immune activity

Overall the Caspase & Granzyme B inhibitors offer significant potential for further understanding cellular processes in research and may have therapeutic applications in the treatment of various diseases

Please note that all services are for research use only. Not intended for any clinical use.

Caspase & Granzyme B Inhibitors